In vitro inhibition of α-glucosidases and glycogen phosphorylase by catechin gallates in green tea

Food Chemistry

Volumn 122, Issue 4, 2010, Pages 1061-1066

  Kamiyama, Ogusa ^a   Sanae, Fujiko ^a   Ikeda, Kyoko ^a   Higashi, Yasuhiko ^a   Minami, Yasuhiro ^a   Asano, Naoki ^a   Adachi, Isao ^b   Kato, Atsushi ^b  

^a HOKURIKU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Glucosidase inhibition; Anti diabetic effect; Gallated catechins; Glycogen phosphorylase inhibition; Green tea extract

Indexed keywords

ALPHA GLUCOSIDASE; CATECHIN; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; GLYCOGEN PHOSPHORYLASE; GREEN TEA EXTRACT;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; DIET SUPPLEMENTATION; DRUG STRUCTURE; ENZYME BINDING; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCONEOGENESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; TEA;

MAMMALIA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 77951938261     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2010.03.075     Document Type: Article

References (30)

1. Boulenc X., Marti E., Joyeux H., Roques C., Berger Y., and Fabre G. Importance of the paracellular pathway for the transport of a new bisphosphonate using the human CACO-2 monolayers model. Biochemical Pharmacology 46 (1993) 1591-1600
2. Cao Y., and Cao R. Angiogenesis inhibited by drinking tea. Nature 398 (1999) 381
3. Ercan-Fang N., and Nuttall F.Q. The effect of caffeine and caffeine analogs on rat liver phosphorylase a activity. The Journal of Pharmacology and Experimental Therapeutics 289 (1997) 1312-1318
4. Fosgerau K., Westergaard N., Quistorff B., Grunnet N., Kristiansen M., and Lundgren K. Kinetic and functional characterization of 1,4-dideoxy-1,4-imino-d-arabinitol: A potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice. Archives of Biochemistry and Biophysics 380 (2000) 274-284
5. Gasparin F.R., Spitzner F.L., Ishii-Iwamoto E.L., Bracht A., and Constantin J. Actions of quercetin on gluconeogenesis and glycolysis in rat liver. Xenobiotica 33 (2003) 903-911
6. Gregoriou M., Nobel M.E.M., Watson K.A., Garman E.F., Krulle T.M., De La Fuente C., et al. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 Å resolution and 100 K: The role of the water structure and its contribution to binding. Protein Science 7 (1998) 915-927
7. Hanefeld M., and Schaper F. Acarbose: Oral anti-diabetes drug with additional cardiovascular benefits. Expert Review of Cardiovascular Therapy 6 (2008) 153-163
8. Ikeda I., Tsuda K., Suzuki Y., Kobayashi M., Unno T., Tomoyori H., et al. Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. Journal of Nutrition 135 (2005) 155-159
9. Juhel C., Armand M., Pafumi Y., Rosier C., Vandermander J., and Lairon D. Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. Journal of Nutritional Biochemistry 11 (2000) 45-51
10. Kasvinsky P.J., Shechosky S., and Fletterick R.J. Synergistic regulation of phosphorylase a by glucose and caffeine. The Journal of Biological Chemistry 253 (1978) 9102-9106
11. Kato A., Nasu N., Takebayashi K., Adachi I., Minami Y., Sanae F., et al. Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase. Journal of Agricultural and Food Chemistry 56 (2008) 4469-4473
12. Kavanagh K.T., Hafer L.J., Kim D.W., Mann K.K., Sherr D.H., Rogers A.E., et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. Journal of Cellular Biochemistry 82 (2001) 387-398
13. Kessler M., Acuto O., Strelli C., Murer H., and Semenza G.A. A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of d-glucose and cholin transport systems. Biochimica et Biophysica Acta 506 (1978) 136-154
14. Maddaiah V.T., and Madsen N.B. Kinetics of purified liver phosphorylase. The Journal of Biological Chemistry 241 (1966) 3873-3881
15. Martin W.H., Hoover D.J., Armento S.J., Stock I.A., McPherson R.K., Danley D.E., et al. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 1776-1781
16. Martin J.L., Veluraja K., Ross K., Johnson L.N., Fleet G.W.J., Ramsden N.G., et al. Glucose analogue inhibitors of glycogen phosphorylase: The design of potential drugs for diabetes. Biochemistry 30 (1991) 10101-10116
17. Matsui T., Tanaka T., Tamura S., Toshima A., Tamaya K., Miyata Y., et al. α-Glucosidase inhibitory profile of catechins and theaflavins. Journal of Agricultural and Food Chemistry 55 (2007) 99-105
18. Mckay D.L., and Blumberg J.B. The role of tea in human health: An update. Journal of the American College of Nutrition 21 (2002) 1-13
19. McLean J.E., Neidhardt E.A., Grossma T.H., and Hedstrom L. Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate. Biochemistry 40 (2001) 2194-2200
20. Minami Y., Kuriyama C., Ikeda K., Kato A., Takebayashi K., Adachi I., et al. Effect of five-membered sugar mimics on mammalian glycogen-degrading enzymes and various glucosidases. Bioorganic and Medicinal Chemistry 16 (2008) 2734-2740
21. Mitrakou A., Kelly D., Veneman T., Jenssen T., Pangburn T., Reilly J., et al. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39 (1990) 1381-1390
22. Newgard C.B., Hwang P.K., and Fletterick R.J. The family of glycogen phosphorylases: Structure and function. Critical Reviews in Biochemistry and Molecular Biology 24 (1989) 69-99
23. Nonaka G., Kawahara O., and Nishioka I. A new class of dimeric flavan-3ol gallates, theasinensins A and B, and proanthocyanidin gallates from green tea leaf. Chemical and Pharmaceutical Bulletin 31 (1983) 3906-3914
24. Oikonomakos N.G., Tiraidis C., Leonidas D.D., Zographos S.E., Kristiansen M., Jessen C.U., et al. Iminosugars as potential inhibitors of glycogenolysis: Structural insights into the molecular basis of glycogen phosphorylase inhibition. Journal of Medicinal Chemistry 49 (2006) 5687-5701
25. Rath V.L., Ammirati M., Danley D., Ekstrom J.L., Gibbs E.M., Hynes T.R., et al. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Chemistry and Biology 7 (2000) 677-682
26. Rio D., Stewart A.J., Mullen W., Burns J., Lean M.E., Brighenti F., et al. HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. Journal of Agricultural and Food Chemistry 52 (2004) 2807-2815
27. Stanley Mainzen Prince P., and Kamalakkannan N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. Journal of Biochemical and Molecular Toxicology 20 (2006) 96-102
28. Treadway J.L., Mendys P., and Hoover D.J. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opinion on Investigational Drugs 10 (2001) 439-454
29. Wu L.Y., Juan C.C., Ho L.T., Hsu Y.P., and Hwang L.S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. Journal of Agricultural and Food Chemistry 52 (2004) 643-648
30. Yoshida Y., Kiso M., and Goto T. Microwave-assisted extraction of polyphenols from fresh tea shoot. Biochimica et Biophysica Acta 67 (1999) 13-23